Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Angioimmunoblastic T-cell lymphoma
ADR ID BADD_A00235
ADR Hierarchy
01      Blood and lymphatic system disorders
01.11      Lymphomas non-Hodgkin's T-cell
01.11.05      Angioimmunoblastic T-cell lymphomas
01.11.05.001      Angioimmunoblastic T-cell lymphoma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.17      Lymphomas non-Hodgkin's T-cell
16.17.05      Angioimmunoblastic T-cell lymphomas
16.17.05.001      Angioimmunoblastic T-cell lymphoma
Description A disorder characterized by proliferation of arborizing small vessels, prominent immunoblastic proliferations and amorphous acidophilic interstitial material. Clinical manifestations include fever, sweats, weight loss, generalized lymphadenopathy and frequently hepatosplenomegaly. [MeSH]
MedDRA Code 10002449
MeSH ID D007119
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Angioimmunoblastic T-cell lymphoma | Angioimmunoblastic T-cell lymphoma NOS | Angioimmunoblastic (AILD, LgX) (Kiel Classification) | Diffuse large cell lymphoma (Angioimmunoblastic T-cell lymphoma) (Working Formulation) | Diffuse mixed small and large cell lymphoma (Angioimmunoblastic T-cell lymphoma) | IBL-like T-cell lymphoma (Lukes-Collins Classification) | Large cell immunoblastic lymphoma (Angioimmunoblastic T-cell lymphoma) (Working Formulation) | Angioimmunoblastic lymphadenopathy with dysproteinemia | Angioimmunoblastic lymphadenopathy with dysproteinaemia | Angioimmunoblastic lymphadenopathy | Immunoblastic Lymphadenopathy | Angioimmunoblastic Lymphadenopathy | Angioimmunoblastic Lymphadenopathies | Lymphadenopathies, Angioimmunoblastic | Lymphadenopathy, Angioimmunoblastic | Lymphadenopathy, Immunoblastic | Immunoblastic Lymphadenopathies | Lymphadenopathies, Immunoblastic
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00076Allopurinol--
BADD_D00912Fluconazole0.000045%
BADD_D00914Fludarabine0.000112%
BADD_D01253Lenalidomide0.000482%
BADD_D01418Methotrexate0.000284%
BADD_D01567Nilotinib0.000112%
The 1th Page    1    Total 1 Pages